Accuracy of Machine Learning Models to Predict Mortality in COVID-19 Infection Using the Clinical and Laboratory Data at the Time of Admission.
artificial intelligence
covid-19
machine learning
mortality
pandemics
prognosis
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
accepted:
14
10
2021
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
23
11
2021
Statut:
epublish
Résumé
Aim This study aimed to develop a predictive model to predict patients' mortality with coronavirus disease 2019 (COVID-19) from the basic medical data on the first day of admission. Methods The medical data including the demographic, clinical, and laboratory features on the first day of admission of clinically diagnosed COVID-19 patients were documented. The outcome of patients was also recorded as discharge or death. Feature selection models were then implemented and different machine learning models were developed on top of the selected features to predict discharge or death. The trained models were then tested on the test dataset. Results A total of 520 patients were included in the training dataset. The feature selection demonstrated 22 features as the most powerful predictive features. Among different machine learning models, the naive Bayes demonstrated the best performance with an area under the curve of 0.85. The ensemble model of the naive Bayes and neural network combination had slightly better performance with an area under the curve of 0.86. The models had relatively the same performance on the test dataset. Conclusion Developing a predictive machine learning model based on the basic medical features on the first day of admission in COVID-19 infection is feasible with acceptable performance.
Identifiants
pubmed: 34804648
doi: 10.7759/cureus.18768
pmc: PMC8592290
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e18768Informations de copyright
Copyright © 2021, Tabatabaie et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Hum Genet. 2020 Dec;65(12):1075-1082
pubmed: 32699345
J Med Internet Res. 2020 Nov 6;22(11):e24018
pubmed: 33027032
Sci Rep. 2020 Nov 13;10(1):19765
pubmed: 33188232
J Med Virol. 2020 Oct;92(10):1875-1883
pubmed: 32441789
Eur Radiol. 2020 Nov;30(11):6186-6193
pubmed: 32524220
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
Sci Rep. 2020 Oct 30;10(1):18716
pubmed: 33127965
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2219-2230
pubmed: 33395783
Epidemiol Infect. 2020 Aug 04;148:e168
pubmed: 32746957
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
Risk Manag Healthc Policy. 2021 Jan 07;14:31-38
pubmed: 33447107
Ann Transl Med. 2020 Jul;8(14):859
pubmed: 32793703
Int J Med Inform. 2020 Oct;142:104258
pubmed: 32927229
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):337-342
pubmed: 33493853
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403
pubmed: 32334395
Ann Med. 2021 Dec;53(1):257-266
pubmed: 33410720
J Med Internet Res. 2020 Nov 11;22(11):e23128
pubmed: 33035175
N Engl J Med. 2019 Jun 27;380(26):2588
pubmed: 31242379
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1133-1142
pubmed: 32663789
BMJ Support Palliat Care. 2020 Sep 22;:
pubmed: 32963059
Eur Respir J. 2020 Aug 20;56(2):
pubmed: 32616597
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):535-545
pubmed: 32408118
JMIR Med Inform. 2021 Jan 28;9(1):e24973
pubmed: 33455900
BMJ Case Rep. 2020 Sep 9;13(9):
pubmed: 32912893
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
Emerg Radiol. 2020 Dec;27(6):701-710
pubmed: 33119835
Nat Commun. 2021 Feb 8;12(1):848
pubmed: 33558493
BMC Cardiovasc Disord. 2021 Jan 7;21(1):23
pubmed: 33413093